ストックスクリーナーアプリを入手
0.1396
3.66%
-0.0053
プレマーケット:
.13
-0.0096
-6.88%
前日終値:
$0.1449
開ける：
$0.14
24時間の取引高:
1.69M
Relative Volume:
0.14
時価総額：
$1.04M
収益：
$3,000
当期純損益:
$-5.65M
株価収益率:
-0.1115
EPS:
-1.2521
ネットキャッシュフロー:
$-5.88M
1週間 パフォーマンス:
+10.79%
1か月 パフォーマンス:
-16.11%
6か月 パフォーマンス:
-71.21%
1年 パフォーマンス:
-86.77%
1日の値動き範囲:
$0.13
$0.145
1週間の範囲:
$0.127
$0.19
52週間の値動き範囲:
$0.10
$1.20
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Compare VRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.1396 | 1.08M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
453.06 | 113.78B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
719.88 | 75.84B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.70 | 50.55B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.48 | 38.99B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
316.55 | 32.69B | 5.76B | 514.49M | 1.10B | 4.4813 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-31 | 開始されました | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd (VRAX) 最新ニュース
TradingKey - TradingKey
Virax Biolabs Company Profile & Introduction - Moomoo
VRAX.O Technical Analysis & Stock Price Forecast - Intellectia AI
MSN Money - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
VRAX Stock Price, Quote & Chart | VIRAX BIOLABS GROUP LTD (NASDAQ:VRAX) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Virax Biolabs Group Limited Or Stock Short Interest Rises to 71.68% - Quiver Quantitative
VRAX Technical Analysis | Trend, Signals & Chart Patterns | VIRAX BIOLABS GROUP LTD (NASDAQ:VRAX) - ChartMill
Iain David Miller Net Worth (2026) - GuruFocus
Evan Michael Norton Net Worth (2026) - GuruFocus
Foster James Alexander Cunliffe Net Worth (2026) - GuruFocus
Nigel William Mccracken Net Worth (2026) - GuruFocus
Nasdaq most active stocks: - MSN
Virax Biolabs CEO Sets Near-Term Milestones as ViraxImmune Strategy Advances and Valuation Lags - The Globe and Mail
Virax Biolabs (VRAX) Outlines Strategic Vision and Key Milestones - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
VRAX | Virax Biolabs Group Limited Insider Trading - Quiver Quantitative
Virax Biolabs (NASDAQ: VRAX) maps ViraxImmune PAIS plan and notes cash-rich valuation gap - Stock Titan
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Virax Biolabs : Investor Presentation (Virax Biolabs Investor Deck Q2 2026) - marketscreener.com
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - PR Newswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Which stocks are moving on Monday? - ChartMill
These stocks are making the most noise in today's session. - ChartMill
Weekly Recap: Is Virax Biolabs Group Limited stock forming a cup and handleEarnings Beat & Reliable Intraday Trade Plans - baoquankhu1.vn
Dow Dips Over 350 Points; Goldman Sachs Posts Upbeat Earnings - Benzinga
Which stocks are moving before the opening bell on Monday? - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Trending Stocks Today | Virax Biolabs Soars 88.08% Pre-Market - Moomoo
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
VRAX.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VRAX.O PE Ratio & Valuation, Is VRAX.O Overvalued - Intellectia AI
Aug Weekly: Will Virax Biolabs Group Limited outperform the market in YEAREarnings Recap Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Trending Stocks Today | Virax Biolabs Surges 62.43% Post-Market - Moomoo
Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement - TipRanks
Warrant exercises lift Virax Biolabs (VRAX) to 19.9M shares outstanding - Stock Titan
Aug Catalysts: Whats next for Virax Biolabs Group Limited stock2026 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
9 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
VIRAX BIOLABS GROUP PB Ratio: 0.17 — 71% Below Median - GuruFocus
VRAX Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Virax Biolabs Group Ltd (VRAX) 財務データ
収益
当期純利益
現金流量
EPS
0.58%
3.00%
大文字化:
|
ボリューム (24 時間):